Perivascular epithelial remodeling is reflected in circulating cfDNA methylation signals as detection markers for early esophageal tumorigenesis
Early detection of esophageal squamous cell carcinoma (ESCC) is hindered by a lack of noninvasive biomarkers for precancerous lesions. Here, we report a circulating cell-free DNA (cfDNA) methylation approach for early esophageal neoplasia detection. In prospective community screening, the assay achieved standardized sensitivity of 78% at 79% specificity for the clinically actionable endpoint of high-grade intraepithelial neoplasia (HGIN) or ESCC, with stage-specific sensitivities of 76% for HGIN and 86% for ESCC. Genome-wide methylation profiling reveals HGIN as an early epigenetic reprogramming stage. Integrative spatial and single-cell RNA sequencing reveals pronounced remodeling of the endothelial-proximal epithelial cell population, whose methylation signatures are detected in cfDNA. Guided by these findings, we develop an 11-gene cfDNA methylation panel that shows robust discrimination of early-stage ESCC across three retrospective case-control sets and an independent screening-derived case-control set. Together, these results demonstrate that our cfDNA methylation panel has promising utility for early ESCC detection.
Authors
- Yunlong Cao (ORCID: https://orcid.org/0000-0001-5918-1078)
- Zhixuan Xuan (ORCID: https://orcid.org/0009-0006-1585-2320)
- Jiang Chang (ORCID: https://orcid.org/0000-0001-8551-9458)
- Shaokai Zhang (ORCID: https://orcid.org/0009-0009-7895-0763)
- Chen Hsuan Wu (ORCID: https://orcid.org/0000-0003-4954-1011)
- Ge Gao (ORCID: https://orcid.org/0000-0001-6470-8815)
- Yuan Lin (ORCID: https://orcid.org/0000-0001-8961-8971)
- Qingyi Liu (ORCID: https://orcid.org/0009-0001-1313-8418)
- Yin Liu (ORCID: https://orcid.org/0000-0003-0961-2276)
- Chenxi Feng (ORCID: https://orcid.org/0009-0001-4117-8310)
- Dongxin Lin (ORCID: https://orcid.org/0000-0002-8723-8868)
- Yali Bai (ORCID: https://orcid.org/0000-0003-2220-9692)
- Ziyi He (ORCID: https://orcid.org/0000-0002-5287-5728)
- Yonglin Yi (ORCID: https://orcid.org/0009-0005-5386-4384)
- Yang Ding (ORCID: https://orcid.org/0000-0002-6543-4075)
- Dongxu Li (ORCID: https://orcid.org/0009-0009-9581-275X)
- Hanzhang Yi (ORCID: https://orcid.org/0009-0005-0686-7566)
- Chenying Li (ORCID: https://orcid.org/0009-0007-2589-1208)
- Mengxi Gao (ORCID: https://orcid.org/0009-0004-6048-0429)
- Jiachen Li (ORCID: https://orcid.org/0009-0007-0800-4339)
- Kai Li (ORCID: https://orcid.org/0009-0005-0147-7200)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Peking Union Medical College Hospital (CN)
- Zhengzhou University (CN)
- Cancer Hospital of Chinese Academy of Medical Sciences (CN)
- Henan Cancer Hospital (CN)
- Beijing Tsinghua Chang Gung Hospital (CN)
- Huazhong University of Science and Technology Hospital (CN)
- Changping Laboratory (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Cancer Discovery
- Published
- 2026-11-12
- DOI
- https://doi.org/10.1158/2159-8290.cd-26-0691
- Primary Topic
- Epigenetics and DNA Methylation
- Type
- article
- Field-Weighted Citation Impact
- 0.00